Since a lack of apoptosis may result in tumour resistance and relapse, more research on the interaction of TRAIL with pro-survival and apoptotic pathways is crucial to improve the effectiveness of anticancer therapy. This evidence concerns the gene TNFSF10 and neoplasm.